Penumbra (PEN) Stock Forecast, Price Target & Predictions
PEN Stock Forecast
Penumbra stock forecast is as follows: an average price target of $224.85 (represents a -6.50% downside from PEN’s last price of $240.49) and a rating consensus of 'Buy', based on 14 wall street analysts offering a 1-year stock forecast.
PEN Price Target
PEN Analyst Ratings
Buy
Penumbra Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 31, 2024 | Matt O'Brien | Piper Sandler | $235.00 | $211.29 | 11.22% | -2.28% |
Oct 31, 2024 | Pito Chickering | Deutsche Bank | $241.00 | $211.29 | 14.06% | 0.21% |
Oct 18, 2024 | Matt O'Brien | Piper Sandler | $225.00 | $202.26 | 11.24% | -6.44% |
Oct 16, 2024 | Jason Mills | Canaccord Genuity | $235.00 | $206.62 | 13.74% | -2.28% |
Oct 15, 2024 | David Rescott | Robert W. Baird | $244.00 | $211.36 | 15.44% | 1.46% |
Oct 14, 2024 | Richard Newitter | Truist Financial | $235.00 | $214.92 | 9.34% | -2.28% |
Oct 08, 2024 | Shagun Singh | RBC Capital | $222.00 | $190.81 | 16.35% | -7.69% |
Sep 17, 2024 | Matthew Blackman | Stifel Nicolaus | $238.00 | $187.06 | 27.23% | -1.04% |
Sep 03, 2024 | Mike Kratky | Leerink Partners | $263.00 | $202.32 | 29.99% | 9.36% |
Jul 31, 2024 | Richard Newitter | Truist Financial | $200.00 | $173.09 | 15.55% | -16.84% |
10
Penumbra Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 2 | 9 | 16 |
Avg Price Target | $238.00 | $237.56 | $218.44 |
Last Closing Price | $240.49 | $240.49 | $240.49 |
Upside/Downside | -1.04% | -1.22% | -9.17% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 31, 2024 | RBC Capital | Outperform | Outperform | Hold |
Oct 31, 2024 | Deutsche Bank | Buy | Buy | Hold |
Oct 18, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Oct 16, 2024 | Canaccord Genuity | Buy | Buy | Hold |
Oct 15, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Oct 14, 2024 | BTIG | Buy | Buy | Hold |
Oct 08, 2024 | RBC Capital | Outperform | Outperform | Hold |
Aug 28, 2024 | BTIG | Buy | Buy | Hold |
Aug 22, 2024 | Citigroup | Neutral | Neutral | Hold |
Jul 31, 2024 | Wells Fargo | - | Equal-Weight | Downgrade |
10
Penumbra Financial Forecast
Penumbra Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $270.95M | $261.50M | $241.40M | $221.22M | $213.68M | $208.34M | $203.90M | $204.01M | $190.12M | $184.26M | $169.20M | $166.90M | $151.08M | $105.11M | $137.33M | $145.26M | $139.50M |
Avg Forecast | $406.29M | $389.31M | $387.39M | $361.01M | $360.34M | $345.21M | $338.12M | $316.36M | $311.38M | $297.36M | $298.24M | $275.20M | $286.62M | $265.38M | $253.59M | $229.68M | $217.33M | $212.49M | $206.24M | $195.39M | $194.29M | $181.06M | $170.77M | $152.64M | $155.40M | $124.95M | $100.74M | $136.28M | $141.40M | $133.98M |
High Forecast | $413.25M | $395.98M | $394.03M | $367.20M | $366.51M | $351.13M | $343.92M | $320.45M | $316.14M | $298.19M | $298.24M | $275.40M | $289.63M | $267.32M | $257.94M | $233.62M | $221.05M | $212.49M | $206.24M | $195.39M | $194.29M | $181.06M | $170.77M | $152.64M | $155.40M | $124.95M | $100.74M | $136.28M | $141.40M | $133.98M |
Low Forecast | $398.33M | $381.69M | $379.81M | $353.94M | $353.29M | $338.46M | $331.51M | $310.97M | $309.11M | $296.53M | $298.24M | $275.01M | $283.25M | $264.12M | $248.63M | $225.19M | $213.08M | $212.49M | $206.24M | $195.39M | $194.29M | $181.06M | $170.77M | $152.64M | $155.40M | $124.95M | $100.74M | $136.28M | $141.40M | $133.98M |
# Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 13 | 7 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.03% | 1.05% | 1.02% | 1.01% | 1.01% | 1.04% | 1.05% | 1.05% | 1.08% | 1.11% | 1.07% | 1.21% | 1.04% | 1.01% | 1.03% | 1.04% |
Forecast
Penumbra EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 13 | 7 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $12.63M | $17.89M | $8.01M | $4.83M | $11.66M | $5.79M | $1.68M | $-35.20M | $12.23M | $14.69M | $16.85M | $3.96M | $-15.33M | $-12.96M | $2.75M | $14.45M | $15.50M |
Avg Forecast | $13.85M | $13.27M | $13.20M | $12.30M | $12.28M | $11.76M | $11.52M | $10.78M | $10.61M | $10.13M | $10.16M | $980.22K | $9.77M | $9.04M | $8.64M | $1.05M | $-53.86M | $5.71M | $5.54M | $1.12M | $5.22M | $4.86M | $4.59M | $16.85M | $4.17M | $3.36M | $2.71M | $4.18M | $3.80M | $3.60M |
High Forecast | $14.08M | $13.49M | $13.43M | $12.51M | $12.49M | $11.97M | $11.72M | $10.92M | $10.77M | $10.16M | $10.16M | $1.18M | $9.87M | $9.11M | $8.79M | $1.26M | $-43.09M | $5.71M | $5.54M | $1.35M | $5.22M | $4.86M | $4.59M | $20.22M | $4.17M | $3.36M | $2.71M | $5.01M | $3.80M | $3.60M |
Low Forecast | $13.57M | $13.01M | $12.94M | $12.06M | $12.04M | $11.53M | $11.30M | $10.60M | $10.53M | $10.11M | $10.16M | $784.18K | $9.65M | $9.00M | $8.47M | $838.70K | $-64.63M | $5.71M | $5.54M | $897.00K | $5.22M | $4.86M | $4.59M | $13.48M | $4.17M | $3.36M | $2.71M | $3.34M | $3.80M | $3.60M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.40% | 2.07% | 7.64% | -0.09% | 2.04% | 1.05% | 1.50% | -6.75% | 2.52% | 3.20% | 1.00% | 0.95% | -4.57% | -4.79% | 0.66% | 3.81% | 4.31% |
Forecast
Penumbra Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 13 | 7 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $9.21M | $18.96M | $8.56M | $3.88M | $-2.27M | $-3.69M | $79.00K | $-24.63M | $8.85M | $9.23M | $11.84M | $3.65M | $-8.81M | $-11.96M | $1.43M | $9.69M | $11.48M |
Avg Forecast | $57.29M | $47.73M | $41.81M | $34.73M | $45.34M | $40.60M | $35.89M | $27.86M | $34.63M | $26.92M | $21.77M | $134.67K | $27.38M | $17.80M | $10.96M | $144.04K | $-37.69M | $-149.16K | $-1.21M | $154.05K | $6.85M | $6.28M | $6.38M | $11.84M | $3.36M | $-3.77M | $-16.80M | $2.16M | $7.45M | $6.55M |
High Forecast | $58.56M | $48.80M | $42.74M | $35.50M | $46.35M | $41.50M | $36.69M | $37.03M | $42.03M | $27.52M | $21.78M | $161.61K | $33.55M | $20.96M | $11.20M | $172.84K | $-30.15M | $-149.16K | $-1.21M | $184.86K | $6.85M | $6.28M | $6.38M | $14.20M | $3.36M | $-3.77M | $-16.80M | $2.60M | $7.45M | $6.55M |
Low Forecast | $55.83M | $46.52M | $40.74M | $33.84M | $44.19M | $39.57M | $34.98M | $20.81M | $28.80M | $26.31M | $21.76M | $107.74K | $22.36M | $15.82M | $10.68M | $115.23K | $-45.23M | $-149.16K | $-1.21M | $123.24K | $6.85M | $6.28M | $6.38M | $9.47M | $3.36M | $-3.77M | $-16.80M | $1.73M | $7.45M | $6.55M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.52% | 1.73% | 59.44% | -0.10% | 15.23% | 3.04% | 0.51% | -3.60% | 1.41% | 1.45% | 1.00% | 1.09% | 2.34% | 0.71% | 0.66% | 1.30% | 1.75% |
Forecast
Penumbra SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 13 | 7 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $125.92M | $127.44M | $123.08M | $115.63M | $108.57M | $114.61M | $110.90M | $113.50M | $94.40M | $90.64M | $79.80M | $76.60M | $76.16M | $59.85M | $74.45M | $74.69M | $69.29M |
Avg Forecast | $205.24M | $196.67M | $195.70M | $182.37M | $182.03M | $174.39M | $170.81M | $159.82M | $157.30M | $150.22M | $150.66M | $189.06M | $144.79M | $134.06M | $128.11M | $202.20M | $173.65M | $107.34M | $104.19M | $98.71M | $98.15M | $91.46M | $86.27M | $79.80M | $78.51M | $63.12M | $50.89M | $113.06M | $71.43M | $67.68M |
High Forecast | $208.76M | $200.04M | $199.05M | $185.50M | $185.15M | $177.38M | $173.74M | $161.88M | $159.70M | $150.64M | $150.66M | $226.87M | $146.31M | $135.04M | $130.30M | $242.64M | $208.39M | $107.34M | $104.19M | $98.71M | $98.15M | $91.46M | $86.27M | $95.76M | $78.51M | $63.12M | $50.89M | $135.67M | $71.43M | $67.68M |
Low Forecast | $201.23M | $192.82M | $191.87M | $178.80M | $178.47M | $170.98M | $167.47M | $157.10M | $156.15M | $149.80M | $150.66M | $151.24M | $143.09M | $133.42M | $125.60M | $161.76M | $138.92M | $107.34M | $104.19M | $98.71M | $98.15M | $91.46M | $86.27M | $63.84M | $78.51M | $63.12M | $50.89M | $90.44M | $71.43M | $67.68M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 0.99% | 0.61% | 0.67% | 1.01% | 1.10% | 1.12% | 1.16% | 1.03% | 1.05% | 1.00% | 0.98% | 1.21% | 1.18% | 0.66% | 1.05% | 1.02% |
Forecast
Penumbra EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 13 | 7 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.24 | $0.49 | $0.22 | $0.10 | $-0.06 | $-0.10 | - | $-0.66 | $0.24 | $0.25 | $0.32 | $0.10 | $-0.24 | $-0.34 | $0.04 | $0.28 | $0.33 |
Avg Forecast | $1.46 | $1.22 | $1.07 | $0.89 | $1.16 | $1.04 | $0.92 | $0.71 | $0.88 | $0.69 | $0.56 | $0.39 | $0.70 | $0.45 | $0.28 | $0.11 | $0.15 | $-0.00 | $-0.03 | $0.04 | $0.18 | $0.16 | $0.16 | $0.09 | $0.09 | $-0.10 | $-0.43 | $0.13 | $0.19 | $0.17 |
High Forecast | $1.49 | $1.25 | $1.09 | $0.91 | $1.18 | $1.06 | $0.94 | $0.95 | $1.07 | $0.70 | $0.56 | $0.39 | $0.86 | $0.54 | $0.29 | $0.11 | $0.15 | $-0.00 | $-0.03 | $0.04 | $0.18 | $0.16 | $0.16 | $0.09 | $0.09 | $-0.10 | $-0.43 | $0.13 | $0.19 | $0.17 |
Low Forecast | $1.43 | $1.19 | $1.04 | $0.86 | $1.13 | $1.01 | $0.89 | $0.53 | $0.73 | $0.67 | $0.56 | $0.38 | $0.57 | $0.40 | $0.27 | $0.11 | $0.14 | $-0.00 | $-0.03 | $0.04 | $0.18 | $0.16 | $0.16 | $0.09 | $0.09 | $-0.10 | $-0.43 | $0.13 | $0.19 | $0.17 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.53% | 1.75% | 2.02% | 0.68% | 15.58% | 3.12% | 0.05% | -3.74% | 1.48% | 1.52% | 3.56% | 1.16% | 2.47% | 0.79% | 0.30% | 1.46% | 1.95% |
Forecast
Penumbra Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
TNDM | Tandem Diabetes Care | $30.74 | $79.05 | 157.16% | Buy |
IRTC | iRhythm | $73.90 | $121.17 | 63.96% | Buy |
TMDX | TransMedics Group | $79.34 | $126.75 | 59.76% | Buy |
INMD | InMode | $18.49 | $27.50 | 48.73% | Hold |
LIVN | LivaNova | $51.70 | $70.50 | 36.36% | Buy |
CNMD | CONMED | $71.71 | $96.00 | 33.87% | Buy |
NARI | Inari Medical | $49.75 | $66.11 | 32.88% | Buy |
INSP | Inspire Medical Systems | $186.19 | $239.55 | 28.66% | Buy |
DXCM | DexCom | $74.46 | $81.36 | 9.27% | Buy |
PODD | Insulet | $262.00 | $274.00 | 4.58% | Buy |
ITGR | Integer | $135.88 | $138.00 | 1.56% | Buy |
MASI | Masimo | $169.12 | $161.83 | -4.31% | Buy |
PEN | Penumbra | $240.49 | $224.85 | -6.50% | Buy |
SWAV | ShockWave Medical | $334.75 | $258.17 | -22.88% | Hold |